Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Author:
Canada | Publication | March 26, 2020 - 7 PM ET
Based on the government announcements:
Workers
Workers must be at least 15 years of age, a resident in Canada and, for 2019 or in the 12-month period preceding their application, have a total income of at least $5,000 (or any other amount determined by regulation) from:
Eligibility
To be eligible, workers must:
1. Have involuntarily ceased to carry on their employment for reasons related to COVID-19 for at least 14 consecutive days including in the period of four weeks for which they are applying for CERB; and
2. Not receive, during that period:
CERB application
The application procedure, including its formalities, will be determined by regulation. The application may cover any period of four weeks included between March 15, 2020, and October 3, 2020. No CERB application may be submitted after December 2, 2020.
Amounts and duration of CERB
The amount of CERB to which the eligible worker is entitled for one given week will be determined by regulation, as it is not specified in the Act. Furthermore, the regulation could treat various categories of workers differently. In all cases, the CERB may be paid only up to 16 weeks or for the number of weeks to be determined by regulation.
Record of employment
The employer must produce a record of employment each time there is an interruption of earnings for one of its employees. Such an interruption of earnings occurs when employees:
Publication
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Publication
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023